ABLYNX (ABLYF) Set to Announce Earnings on Thursday

ABLYNX (OTCMKTS:ABLYF) is scheduled to post its quarterly earnings results after the market closes on Thursday, February 22nd. Analysts expect ABLYNX to post earnings of ($0.21) per share for the quarter.

Shares of ABLYNX (OTCMKTS:ABLYF) opened at $53.85 on Thursday. ABLYNX has a 52-week low of $11.10 and a 52-week high of $54.75.

A number of analysts recently issued reports on the company. ValuEngine raised ABLYNX from a “sell” rating to a “hold” rating in a research report on Friday, February 2nd. Zacks Investment Research raised ABLYNX from a “hold” rating to a “buy” rating and set a $25.00 price objective for the company in a research report on Wednesday, November 22nd. Finally, Bank of America assumed coverage on ABLYNX in a research report on Friday, November 10th. They set a “buy” rating and a $26.00 price objective for the company.

WARNING: “ABLYNX (ABLYF) Set to Announce Earnings on Thursday” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this news story can be read at https://www.americanbankingnews.com/2018/02/15/ablynx-ablyf-set-to-announce-earnings-on-thursday.html.

ABLYNX Company Profile

Ablynx NV, a biopharmaceutical company, develops Nanobodies that is a proprietary therapeutic protein based on single-domain antibody fragments for the treatment of various diseases. The company develops products in various therapeutic areas, such as inflammation, hematology, immuno-oncology, oncology, and respiratory diseases.

Receive News & Ratings for ABLYNX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ABLYNX and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply